• Issue

    Journal of Surgical Oncology: Volume 109, Issue 3

    177-293
    March 1, 2014
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Commentary

The overdiagnosis theory in lung cancer screening: Does it make any sense?

Russell S. Kussman MD, JD, 
  • Pages: 177-178
  • First Published: 19 November 2013

Research Articles

Does the mode of surgical resection affect the prognosis/recurrence in patients with thymoma?

Kazuo Nakagawa MD,  Hisao Asamura MD,  Hiroyuki Sakurai MD,  Shun-Ichi Watanabe MD,  Koji Tsuta MD, 
  • Pages: 179-183
  • First Published: 19 November 2013

Long-term outcome following surgical treatment of sacral chordoma

Shunzo Osaka MD, PhD,  Eiji Osaka MD, PhD,  Toshio Kojima MD, PhD,  Yukihiro Yoshida MD, PhD,  Yasuaki Tokuhashi MD, PhD, 
  • Pages: 184-188
  • First Published: 19 November 2013

TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer

Kazuya Shinmura MD, PhD,  Shinichiro Kiyose BS,  Kiyoko Nagura BS,  Hisaki Igarashi BS,  Yusuke Inoue MD,  Satoki Nakamura MD, PhD,  Matsuyoshi Maeda MD, PhD,  Megumi Baba MD, PhD,  Hiroyuki Konno MD, PhD,  Haruhiko Sugimura MD, PhD, 
  • Pages: 189-197
  • First Published: 31 October 2013

Appropriate gastrectomy resection margins for early gastric carcinoma

Beom Su Kim MD,  Seong Tae Oh MD,  Jeong Hwan Yook MD,  Hee Sung Kim MD,  In Seob Lee MD,  Byung Sik Kim MD, PhD, 
  • Pages: 198-201
  • First Published: 19 November 2013
Open Access

The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction

Nathan J. Curtis,  Fergus Noble,  Ian S. Bailey MS, FRCS,  Jamie J. Kelly FRCS,  James P. Byrne MD, FRCS,  Timothy J. Underwood PhD, FRCS, 
  • Pages: 202-207
  • First Published: 14 November 2013

Efficacy of endoscopic gastroduodenal stenting for gastric outlet obstruction due to unresectable advanced gastric cancer: A prospective multicenter study

Shunji Endo MD,  Shuji Takiguchi MD,  Yasuhiro Miyazaki MD,  Kazuhiro Nishikawa MD,  Hiroshi Imamura MD,  Ko Takachi MD,  Yutaka Kimura MD,  Atsushi Takeno MD,  Shigeyuki Tamura MD,  Masaki Mori MD,  Yuichiro Doki MD,  on behalf of the CLINICAL STUDY GROUP OF OSAKA UNIVERSITY (CSGO), UPPER GI GROUP , 
  • Pages: 208-212
  • First Published: 06 November 2013

Photodynamic diagnosis using 5-aminolevulinic acid during gastrectomy for gastric cancer

Tsutomu Namikawa PhD, MD,  Keiji Inoue PhD, MD,  Sunao Uemura MD,  Mai Shiga MD,  Hiromichi Maeda PhD, MD,  Hiroyuki Kitagawa PhD, MD,  Hideo Fukuhara PhD, MD,  Michiya Kobayashi PhD, MD,  Taro Shuin PhD, MD,  Kazuhiro Hanazaki PhD, MD, 
  • Pages: 213-217
  • First Published: 08 November 2013

Ability of FDG-PET/CT in the detection of gallbladder cancer

Carlos Ramos-Font MD, PhD,  Manuel Gómez-Rio MD, PhD,  Antonio Rodríguez-Fernández MD, PhD,  Amelia Jiménez-Heffernan MD, PhD, FEBNM, FASNC,  Rocío Sánchez Sánchez MD, PhD,  Jose Manuel Llamas-Elvira MD, PhD, 
  • Pages: 218-224
  • First Published: 25 October 2013

Editorial

Prevention and early treatment of peritoneal metastases from colorectal cancer: Second-look laparotomy or prophylactic HIPEC?

Dario Baratti MD,  Shigeki Kusamura PhD,  Marcello Deraco MD, 
  • Pages: 225-226
  • First Published: 22 January 2014

Research Articles

Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI

Shimpei Ogawa MD, PhD,  Michio Itabashi MD, PhD,  Tomoichiro Hirosawa MD, PhD,  Takuzo Hashimoto MD, PhD,  Yoshiko Bamba MD, PhD,  Shingo Kameoka MD, PhD, 
  • Pages: 227-233
  • First Published: 25 October 2013

Prognostic significance of lymph node status in patients with metastatic colorectal carcinoma treated with lymphadenectomy

Yan-Long Liu MD,  Hai-tao Xu MD,  Shi-Xiong Jiang MD,  Yan-Mei Yang MD,  Bin-Bin Cui MD, 
  • Pages: 234-238
  • First Published: 21 January 2014

Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis

Yong Sik Yoon MD,  Chan Wook Kim MD,  Seok-Byung Lim MD,  Chang Sik Yu MD,  So Yeon Kim MD,  Tae Won Kim MD,  Min-Ju Kim BS,  Jin Cheon Kim MD, 
  • Pages: 239-244
  • First Published: 25 October 2013

Clinicopathological aspects of adenocarcinoma of the large bowel in a low incidence population

Jonathan C.B. Dakubo Bsc(HB), MBCHB, FWCS, FGCS,  Simon S.B. Naaeder MBChB, MD (UG), FRCS, FWCS, FGCS,  Richard K. Gyasi MBChB, FWACP, FGCP, 
  • Pages: 245-249
  • First Published: 19 November 2013

Pretreatment selection of regimen according to genetic analysis improves the efficacy of chemotherapy in the first line treatment of metastatic colorectal cancer

Do Yoon Kim MD,  Tae Yoon Paek MD, PhD,  Seung Yeop Oh MD, PhD,  Young Bae Kim MD, PhD,  Je Hee Lee MD, PhD,  Mi Young Lee MS,  Zi Sun Choi MD,  Kwang Wook Suh MD, PhD, 
  • Pages: 250-254
  • First Published: 07 December 2013

Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence

Eric J.Th. Belt MD, PhD,  Hein B.A.C. Stockmann MD, PhD,  Pien M. Delis-van Diemen MSc,  Herman Bril MD, PhD,  Marianne Tijssen MSc,  Hendrik F. van Essen MSc,  Martijn W. Heymans PhD,  Jeroen A.M. Beliën MD, PhD,  Beatriz Carvalho PhD,  Saskia A.G.M. Cillessen PhD,  Gerrit A. Meijer MD, PhD, 
  • Pages: 255-265
  • First Published: 19 November 2013

Should a loop ileostomy closure in rectal cancer patients be done during or after adjuvant chemotherapy?

Dr. Hagit Tulchinsky MD,  Einat Shacham-Shmueli MD,  Joseph M. Klausner MD,  Moshe Inbar MD,  Ravit Geva MD, 
  • Pages: 266-269
  • First Published: 19 November 2013

Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: A series of 39 patients treated with palliative intent

Nicola Solari MD,  Francesco Spagnolo MD,  Erica Ponte MD,  Alberto Quaglia MD,  Roberto Lillini PhD,  Michela Battista MS,  Paola Queirolo MD,  Ferdinando Cafiero MD, 
  • Pages: 270-274
  • First Published: 28 October 2013

Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma

Dae-Geun Jeon MD,  Chang-Bae Kong MD,  Wan Hyeong Cho MD,  Won Seok Song MD,  Sang Hyun Cho MD,  Sung Woo Choi MD,  Soo-Yong Lee MD, 
  • Pages: 275-279
  • First Published: 14 November 2013

Pulmonary neuroendocrine tumors: Study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses

Yi-Chen Yeh MD,  Teh-Ying Chou MD, PhD, 
  • Pages: 280-286
  • First Published: 03 December 2013

Multimodal treatment of locally advanced esophageal adenocarcinoma: Which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients

Jens Hoeppner MD,  Katja Zirlik MD,  Thomas Brunner MD,  Peter Bronsert MD,  Birte Kulemann MD,  Olivia Sick,  Goran Marjanovic MD,  Ulrich Theodor Hopt MD,  Frank Makowiec MD, 
  • Pages: 287-293
  • First Published: 26 November 2013